Header Logo

Connection

Susan Meiring to HIV Infections

This is a "connection" page, showing publications Susan Meiring has written about HIV Infections.
Connection Strength

1,066
  1. Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020. Int J Infect Dis. 2022 Sep; 122:1056-1066.
    View in: PubMed
    Score: 0,224
  2. Human Immunodeficiency Virus Infection Is Associated With Increased Meningococcal Carriage Acquisition Among First-year Students in 2 South African Universities. Clin Infect Dis. 2021 07 01; 73(1):e28-e38.
    View in: PubMed
    Score: 0,208
  3. Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa. PLoS Negl Trop Dis. 2016 07; 10(7):e0004865.
    View in: PubMed
    Score: 0,148
  4. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
    View in: PubMed
    Score: 0,143
  5. Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection. Nat Commun. 2024 Aug 22; 15(1):7240.
    View in: PubMed
    Score: 0,065
  6. Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study. Clin Microbiol Infect. 2023 Aug; 29(8):1063-1069.
    View in: PubMed
    Score: 0,059
  7. Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study. Lancet Infect Dis. 2022 09; 22(9):1365-1373.
    View in: PubMed
    Score: 0,055
  8. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Clin Infect Dis. 2019 07 18; 69(3):495-504.
    View in: PubMed
    Score: 0,045
  9. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis. 2015 May 01; 60(9):1346-56.
    View in: PubMed
    Score: 0,033
  10. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15; 59(6):808-18.
    View in: PubMed
    Score: 0,032
  11. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,010
  12. Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003 - 2008. PLoS One. 2015; 10(10):e0140185.
    View in: PubMed
    Score: 0,009
  13. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
    View in: PubMed
    Score: 0,008
  14. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014 Nov 13; 371(20):1889-99.
    View in: PubMed
    Score: 0,008
  15. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine. 2013 Aug 28; 31(38):4200-8.
    View in: PubMed
    Score: 0,007
  16. Systemic shigellosis in South Africa. Clin Infect Dis. 2012 May; 54(10):1448-54.
    View in: PubMed
    Score: 0,007
  17. Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa. AIDS. 2010 Jun 01; 24(9):1351-60.
    View in: PubMed
    Score: 0,006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.